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KESAN PERENCAT ALK-5 DAN FAKTOR TRANSFORMASI 
PERTUMBUHAN BETA1 DALAM PEMBEZAAN SEL STEM DARI GIGI 
SUSU MANUSIA YANG TERKELUPAS (SHED) KEPADA SEL BERSIFAT 
EPITELIAL 
 
ABSTRAK 
 
Sel stem daripada gigi susu manusia yang terkelupas (SHED) boleh 
membahagi, membeza dan matang kepada sel jenis tertentu dan berupaya 
membaikpulih diri sendiri untuk menghidupkan sel-sel yang lain. Kajian terdahulu 
menunjukkan SHED boleh membeza menjadi sel bersifat epitelial. 
Walaubagaimanapun, kesan-kesan Faktor Transformasi Pertumbuhan Beta1 (TGF-β1) 
atau perencat reseptor aktivin bersifat kinase 5 (ALK-5) ke atas SHED masih belum 
diterokai. Oleh itu, kajian ini bertujuan untuk mengkaji kesan TGF-β1 dan perencat 
ALK-5 ke atas SHED yang dikultur dalam Media Pertumbuhan Keratinocyte (KGM) 
ke atas potensinya untuk membeza kepada sel bersifat epitelial menggunakan asai 
MTT [(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)] dan asai biru 
alamar, analisis morfologi sel, teknik Tindakbalas Rantai Polimerase-Transkriptase 
Berbalik (RT-PCR) dan sitometri aliran (flow cytometry). Analisa sitotoksisiti 
menggunakan asai MTT dijalankan selama 72 jam melalui pencairan bersiri TGF-β1 
(0.3125, 0.625, 1.25, 2.5, 5.0, 10.0, 20.0, 40.0, 80.0, dan 160.0 ng/ml) dan perencat 
ALK-5 (0.156, 0.3125, 0.625, 1.25, 2.5, 5.0, 10.0, 20.0, 40.0, 80.0, dan 160.0 µM). 
Kemudian, tiga kepekatan TGF-β1 (0.3125, 0.625, dan 1.25 ng/ml) dan perencat ALK-
5 (0.156, 0.3125, dan 0.625 µM) yang terpilih digunakan bagi penentuan masa 
penggandaan populasi (PDT) sel melalui asai biru alamar pada hari 1, 3, 5, 7, dan 10, 
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dan pengkulturan SHED di dalam α-MEM. Kajian ini selanjutnya diteruskan dengan 
pemerhatian perubahan morfologi sel ke atas SHED yang dikultur dalam KGM sahaja 
dan dengan kepekatan TGF-β1 (1.25 ng/ml) atau perencat ALK-5 (0.625 µM) terpilih 
pada hari 1, 3, 7, 14, dan 21. Isolasi RNA SHED yang dikultur dalam tiga keadaan 
berbeza ini dilakukan pada hari 1, 3, 7, 14, dan 21. Kemudian, analisis ekspresi gen 
sel stem, sel epitelial, dan gen-gen tertentu yang terlibat dalam isyarat TGF-β 
dikenalpasti sewaktu proses pembezaan menggunakan RT-PCR Dua Langkah. Selain 
daripada itu, analisis ekspresi protein ke atas penanda epitelial juga ditentukan 
menggunakan sitometri aliran pada hari 1 dan 21. Berdasarkan asai MTT, didapati 
kepekatan TGF-β1 pada 0.3125, 0.625, dan 1.25 ng/ml dan perencat ALK-5 pada 
0.156, 0.3125, dan 0.625 µM menunjukkan kesan sitotoksik yang paling minima (lebih 
daripada 50%) dan dipilih untuk asai proliferasi. PDT terpendek diwakili oleh 1.25 
ng/ml TGF-β1 (75 jam) dan 0.625 µM perencat ALK-5 (68 jam) dan kepekatan ini 
termasuklah sel-sel hanya dalam KGM, menunjukkan terdapat perubahan morfologi 
berbanding kawalan. Profil ekspresi penanda epitelial menunjukkan ketiadaan 
pengekspresan gen E-cadherin, ∆Np63, dan Keratin5 beserta protein E-cadherin dan 
pan-sitokeratin yang menunjukkan keadaan kultur yang tidak berupaya meransang 
proses pembezaan SHED kepada sel bersifat epitelial. Walaubagaimanapun, kehadiran 
penanda sel stem (NANOG, nestin, Rex1, dan vimentin) dan molekul spesifik yang 
terlibat dalam isyarat TGF-β (TGFβR1, TGFβ1, Smad3, dan Smad4) menunjukkan 
bahawa kultur sel dalam tiga keadaan berbeza menggalakkan proses peralihan epitelial 
kepada mesenkima (EMT) dengan kehadiran TGFβ1 dan Smad3 dalam isyarat TGF-β 
yang sudah dikaitkan dengan EMT. Oleh yang demikian, KGM tidak dapat 
membezakan SHED sepenuhnya kepada sel seperti sel epitelial dan seterusnya, SHED 
tidak dapat menjalani proses peralihan mesenkima kepada epithelial (MET).  
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EFFECTS OF ALK-5 INHIBITOR AND TRANSFORMING GROWTH 
FACTOR-BETA1 IN THE DIFFERENTIATION OF STEM CELLS FROM 
HUMAN EXFOLIATED DECIDUOUS TEETH (SHED) INTO EPITHELIAL-
LIKE CELLS 
 
ABSTRACT 
 
Stem cells from human exfoliated deciduous teeth (SHED) are capable to 
divide, differentiate and mature to the specific types of cells as well as to replenish 
themselves to regenerate other living cells. Previous study has showed that SHEDs 
could differentiate into epithelial-like cells. Yet, the effects of Transforming Growth 
Factor-Beta1 (TGF-β1) or activin like kinase 5 (ALK-5) inhibitor on SHEDs remain 
unexplored. Thus, the present study was aimed to investigate the effects of TGF-β1 
and ALK-5 inhibitor on SHEDs cultured in Keratinocyte Growth Medium (KGM) on  
its potential to differentiate  into epithelial-like cells employing MTT [(3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)] and alamar blue assays, cell 
morphology analysis, Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
technique and flow cytometry. A serial dilution of TGF-β1 (0.3125, 0.625, 1.25, 2.5, 
5.0, 10.0, 20.0, 40.0, 80.0, and 160.0 ng/ml) and ALK-5 inhibitor (0.156, 0.3125, 
0.625, 1.25, 2.5, 5.0, 10.0, 20.0, 40.0, 80.0, and 160.0 µM) concentration was carried 
out to determine the cell cytotoxicity for each treatment using MTT assay for 72 hours. 
Afterwards, the three selected concentrations for TGF-β1 (0.3125, 0.625, and 1.25 
ng/ml) and ALK-5 inhibitor (0.156, 0.3125, and 0.625 µM) were analysed using 
alamar blue assay on day 1, 3, 5, 7, and 10 and was done in alpha Minimum Essential 
Medium (α-MEM) to determine the population doubling time (PDT). The study was 
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further investigated with observation of the cell morphological changes on SHED 
cultured in KGM only, and with selected concentration of TGF-β1 or ALK-5 inhibitor 
on day 1, 3, 7, 14, and 21. RNA isolation of SHED culture in three different conditions 
were harvested at day 1, 3, 7, 14, and 21. Then, the gene expression analysis of stem 
cell, epithelial cell, and specific genes involved in TGF-β signalling were identified 
during the differentiation process using Two-step RT-PCR. Apart from that, protein 
expression analysis of epithelial markers was also determined using flow cytometer on 
day 1 and 21. Based on MTT assay, 0.3125, 0.625, and 1.25 ng/ml TGF-β1 and 0.156, 
0.3125, and 0.625 µM ALK-5 inhibitor showed less cytotoxicity effects (more than 
50%) and were selected for proliferation assay. The shortest PDT was represented by 
1.25 ng/ml TGF-β1 (75 hours) and 0.625 µM ALK-5 inhibitor (68 hours) and these 
concentrations including cells in KGM only, showed there were cell morphological 
changes compared to control. The gene expression profile showed an absence of 
epithelial markers E-cadherin, ∆Np63, and Keratin5 for gene, and E-cadherin and pan-
cytokeratin for protein expression indicated that the culture conditions unable to 
induce the differentiation process into epithelial-like cells. However, the presence of 
stem cell markers (NANOG, nestin, Rex1, and vimentin) and specific molecules 
involved in TGF-β signalling (TGFβR1, TGFβ1, Smad3, and Smad4) indicated that 
the cell culture in three different condition induced epithelial to mesenchymal 
transition (EMT) since the presence of TGFβ1 and Smad3 in TGF-β signalling that 
have been associated with EMT. Thus, KGM was unable to fully differentiate SHED 
into epithelial-like cells and hence, SHED were incapable to undergo mesenchymal to 
epithelial transition (MET). 
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CHAPTER ONE 
 
INTRODUCTION 
 
1.1 Background of the study 
 
Stem cell (SC) research has been recognised as one of the demanding fields in tissue 
regeneration, engineering, and therapeutic research. SCs are undifferentiated cells 
which are found in the embryonic, fetal, and adult organism. These SCs are capable of 
self-renewal through cell division, clonality, and differentiated into other types of cells 
for cell and tissues survival (Kolios and Moodley, 2013). 
 
Based on their origin and differentiation capabilities, SCs can be categorised 
into two broad groups; embryonic stem cells (ESCs) which are derived from blastocyst 
and stem cells isolated from adult tissues. Both these SCs differ in their potential to 
differentiate into different cell types. ESCs can differentiate into three germ layers; 
endoderm, mesoderm, and ectoderm, besides can be maintained in undifferentiated 
state for a prolonged period in cell culture (Yao et al., 2006). On the other hand, adult 
SCs have been known to have limitation in their differentiation capacity although these 
cells have differentiated into tissue from different germ cell layers in vitro (Ilancheran 
et al., 2009; Moodley et al., 2010). 
 
Adult SCs can be isolated from diverse tissues, including bone marrow, 
muscle, fat, dermis, placenta, dental pulp, synovial membrane, peripheral blood, 
periodontal ligament, endometrium, umbilical cord, and umbilical cord blood 
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(Fukuchi et al., 2004; Sarugaser et al., 2005; Tondreau et al., 2005; Baksh et al., 2007; 
Crisan et al., 2008; Martin‐Rendon et al., 2008; Schwab et al., 2008; Huang et al., 
2009b; Hermida-Gómez et al., 2011; Park et al., 2011b; Singer and Caplan, 2011; 
Eirin et al., 2012). Bobis et al. (2006) reported that mesenchymal stem cells (MSCs) 
were found to be the most abundant among adult SCs. These cells are defined as 
multipotent cells, where they have limited capabilities of specialisation, and they can 
form bone, cartilage, muscle, fat, and other connective tissues when were stimulated 
with cytokine or specific culture medium (Caplan, 2007). In 2009, Nam and Lee 
discovered that stem cells from human exfoliated deciduous teeth (SHED) can be 
induced to differentiate into epithelial-like cells when directly cultured in specific 
media, Keratinocyte Growth Medium (KGM) (Nam and Lee, 2009). Formation of 
epithelium was crucial in tissue regeneration and engineering to regenerate damaged 
human cells due to illness, developmental defects and accidents. 
 
 In view with the advancement in tissue engineering together with stem cell’s 
regeneration potential, researchers started to explore stem cells from different sources 
and one of the promising stem cells are SHED which was first discovered by Miura 
and his colleagues in 2003 (Miura et al., 2003). These stem cells have been considered 
as one of the potential sources since the deciduous tooth was easily accessible and 
extraction of tooth was less invasive compared to other types of stem cells.  
 
Transforming Growth Factor-Beta (TGF-β) family consists of important 
secreted structurally related polypeptides such as TGF-βs, activins, bone 
morphogenetic proteins (BMPs), growth and differentiation factor, Müllerian 
inhibitory factor, and inhibin (Santibañez et al., 2011). This family secreted wide range 
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of proteins involved in many physiological processes including embryonic 
development, immune responses, and wound healing, and cellular biological function 
such as cell proliferation, differentiation, apoptosis, migration, and extracellular matrix 
production (Roberts and Sporn, 1990; Inman et al., 2002; Gordon and Blobe, 2008; 
Wu and Hill, 2009; Gui et al., 2012). Interestingly, TGF-β signalling has been found 
to play an important regulatory function in epithelial proliferation and differentiation 
(Roberts, 1998; Ten Dijke et al., 2002; Lee et al., 2013). The TGF-β consists of three 
isoforms; TGF-β1, TGF-β2, and TGF-β3 and among the isoforms, TGF-β1 was found 
to be the most abundantly and universally expressed isoform (Karatsaidis et al., 2003; 
Dobaczewski et al., 2011), and more studies have been performed using exogenous 
TGF-β1 (Elliott and Blobe, 2005; Gao et al., 2009; Karaöz et al., 2011; Nam et al., 
2014). Treatment with exogenous TGF-β1 have shown a diverse differentiation 
capacities such as in wound healing process in fibroblasts (Penn et al., 2012; Pakyari 
et al., 2013) and epithelial-mesenchymal transition (EMT) (Xu et al., 2009a; Nam et 
al., 2014).   
 
TGF-β receptors involve TGF-βR1, TGF-βR2, and TGF-βR3 and the 
biological processes occurred when TGF-β molecule binds to the cell surface receptor 
TGF-βR2 (Massagué, 1998). TGF-βR1 or identified as activin receptor-like kinase 
(ALK) recognises the heterodimer complex of TGF-β molecule-TGF-βR2 and 
undergoes phosphorylation (Massagué, 2012). Out of seven known type I (Activin like 
kinase; ALK) receptors, ALK-4, ALK-5, and ALK-7 are structurally similar to each 
other (Miyazawa et al., 2002). ALK-5, also known as TGF-βR1 is the specific receptor 
for TGF-βs (Miyazawa et al., 2002; van Meeteren and Ten Dijke, 2012). Once the 
TGF-βR1 is phosphorylated, the downstream regulation occurred and translocated into 
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the nucleus, and later regulated the transcription of certain target genes (Godkin and 
Dore, 1998; Worthington et al., 2012). However, the TGF-β signalling transduction 
could be inhibited in the presence of inhibitory molecules such as (SB431542) [(SB) 
4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]-benzamide]. This 
chemically synthetic substance acts as a potent and specific inhibitor of ALK-5, also 
inhibits ALK-4 and nodal type 1 receptor ALK-7, since they are highly related to ALK-
5 in their kinase domains (Inman et al., 2002). Since SB431542 interacts with 
heterodimer complex of TGFβ type 2 and type 1 (ALK-5) receptor, the activity of 
TGF-β1 might also be affected to a certain extent. Hence, this study aims to study the 
effects of exogenous TGF-β1 and potent inhibitor SB431542 (ALK-5 inhibitor) on 
SHED cultured in differentiation medium enriched for promotion of differentiation 
process into epithelial-like cells.  
 
The current study intended to determine the effects of exogenous TGF-β1 and 
its inhibitor (ALK-5) in the induction of SHED into epithelial-like cells. The SHED 
cultured in KGM were treated with both treatments of TGF-β1 and ALK-5 inhibitor 
and were analysed for cell viability using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] assay, cell proliferation and population doubling time 
(PDT)  using alamar blue assay, and cellular morphology on day 1, 3, 7, 14, and 21. 
Furthermore, gene expression of stem cell markers (NANOG, nestin, Rex1, and 
vimentin), epithelial markers (E-cadherin, ∆Np63, and Keratin5) and specific 
molecules (TGFβR1, TGFβ1, Smad3, and Smad4) involved in TGF-β signalling 
transduction together with protein expression of epithelial markers (E-cadherin and 
pan-cytokeratin) were also investigated. 
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1.2 Justification of study 
 
Human parts such as skin, oral mucosa, and blood vessel are mainly reconstructed by 
epithelial cells. Formation of epithelial cells have become crucial to regenerate new 
cells thus replacing damaged human cells due to illness, developmental defects and 
accidents. SHED has been widely known as one of stem cell sources for therapeutic 
application. The ability of SHED to differentiate to other cell lineage such as epithelial 
cell, when cultured in specific medium highlights its potential for application in future 
tissue regeneration. Interestingly, the novel epithelial stem cell-like cells from SHED 
have been identified recently (Nam and Lee, 2009). This suggests the ability of stem 
cells from human exfoliated deciduous teeth to be differentiated to epithelial-like cells. 
TGF-β1 is a growth factor that is mostly produced by epithelial cells. TGF-β1 is also 
a growth factor that is involved during the process of epithelial-mesenchymal 
interaction during organogenesis. Meanwhile, ALK-5 inhibitor played a role as an 
inhibitor to the TGF-β type 1 receptor (ALK-5) which is involved in TGF-β signalling 
pathway. Although many studies have been done considering the function of TGF-β 
signalling pathway on cell proliferation; the role of TGF-β1 molecule especially in 
controlling the process of epithelial cell differentiation from stem cell is still limited. 
Hence, the effects of the TGF-β1, ALK-5 inhibitor, and the molecules involved in the 
cell signalling pathway in the differentiation process of SHED into epithelial-like cells 
will be identified and highlighted. This study may provide a better insight and 
understanding on the mechanism and cellular signalling works for stem cell and tissue 
regeneration process. 
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1.3 Objectives of the study 
 
1.3.1 General Objective 
 
To study the effect of TGF-β1 and its inhibitor (ALK-5) in the differentiation of SHED 
into epithelial-like cells when cultured in KGM. 
 
1.3.2 Specific objectives 
 
i. To determine the population doubling time of SHED treated with TGF-β1 and 
ALK-5 inhibitor when cultured in KGM.  
ii. To measure the gene expression levels of specific gene markers for epithelial-like 
cells derived from SHED treated with TGF-β1 and ALK-5 inhibitor. 
iii. To identify the protein expression of epithelial markers (E-Cadherin and pan-
cytokeratin) on epithelial-like cells derived from SHED treated with TGF-β1 and 
ALK-5 inhibitor. 
iv. To determine the gene expression levels of specific molecules associated in TGF-β 
cell signalling pathway (TGFβR1, TGFβ1, Smad3, and Smad4) in SHED treated 
TGF-β1 and ALK-5 inhibitor when cultured in KGM. 
 
1.4 Research hypothesis 
 
TGF-β1 and ALK-5 inhibitor treatment could affect the differentiation process of 
SHED into epithelial-like cells when cultured in KGM. 
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CHAPTER TWO 
 
LITERATURE REVIEW 
 
2.1 Stem cells 
 
Stem cells are generally defined as unspecialised cells that have capabilities of both 
self-renewal and multi-lineage differentiation into more specialised cells with new 
specialised cells function (Bongso and Lee, 2005; Saxena et al., 2010; Wei et al., 
2013). In mammals, stem cells has been broadly classified into two types; ESCs and 
adult stem cells (Choumerianou et al., 2008; Liu and Cao, 2010; Romeo et al., 2012; 
Venkatesan and Madhira, 2014).  
 
ESCs originated from inner cell mass of blastocysts, which form after a few 
days of fertilisation between egg and sperm fusion. These cells then form three primary 
germ layers which consist of ectoderm, mesoderm, and endoderm (Choumerianou et 
al., 2008; Poh et al., 2014). These cells had been proven to have capability to form 
cells of all tissues in adult organisms (De Wert and Mummery, 2003; Can, 2008; Liu 
and Cao, 2010; Liu et al., 2013). Therefore, ESCs are termed as pluripotent stem cells.  
 
Although ESCs offer fully developed organisms due to its capabilities, there 
are some issues pertaining to ESCs that need to be concerned. The advantage of using 
ESCs was their unlimited differentiation into other types of cells. This unlimited 
potential may offer numerous medical possibilities since ESCs can generate any other 
part of cells and tissues, and cure any possibilities of disease that threaten human life. 
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Meanwhile, the main disadvantage of using ESCs was the human blastocysts were 
destroyed during the process of harvesting the inner mass. This purpose was unethical 
procedure since it involved a human life. Another disadvantage of using ESCs was 
that the proliferation and differentiation of the cells can lead to cancerous and 
unwanted growth of tissues (Baraniak and McDevitt, 2010; Herberts et al., 2011; 
Penna et al., 2015). 
 
On the other hand, adult stem cells have been discovered in wide range of 
tissues of foetus and after birth. These cells have been differentiated into more 
specialised cells where they acted as repair system for the body by replenishing the 
adult tissues during normal or injured situation (De Wert and Mummery, 2003; Hsu 
and Fuchs, 2012). Thus, these adult stem cells had been termed as multipotent stem 
cells. 
 
In 2006, Bobis and his colleagues reported that MSCs had been found to be the 
widest distribution among various adult stem cells in the human body and had been 
isolated from diverse tissues and organs (Bobis et al., 2006). Since the isolated MSCs 
contained high mixture of stromal progenitor cells at various stages of development 
(Rhodes et al., 2004; Maria et al., 2007; Phinney, 2007; Baer and Geiger, 2012), the 
International Society for Cellular Therapy recommended to change the term 
mesenchymal stem cells to multipotent mesenchymal stromal cells (MSCs) (Dominici 
et al., 2006). 
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2.2 Multipotent mesenchymal stem cells  
 
Multipotent mesenchymal stem cells, are progenitor cells which have limited 
capabilities of specialisation. These MSCs have the ability to rise into tri-lineages 
which are osteogenic, chondrogenic, and adipogenic under a standard in vitro 
differentiation medium (Dominici et al., 2006; Liu and Cao, 2010). These post-natal 
cells were isolated from other non-marrow tissues such as adipose tissue, placenta, 
amniotic fluid, tendon, synovial membrane, skeletal muscle and dental pulp (De Bari 
et al., 2001; Shi and Gronthos, 2003; Igura et al., 2004; Tsai et al., 2004; Xu et al., 
2005; Bi et al., 2007; Crisan et al., 2008; Castrechini et al., 2010; Levi and Longaker, 
2011; de Sousa et al., 2014; Machado et al., 2015; Savickiene et al., 2015; Zhang et 
al., 2016). These findings were supported by Baksh et al. (2004), Kolf et al. (2007), 
and Porada et al. (2006) that in the last decade, studies on MSCs had led to the 
discovery of a wide range of stem cells isolated from every organ and tissue (De Bari 
et al., 2001; Huang et al., 2009b). 
 
MSCs have been reported to be easily expanded in vitro although they were 
found in very small quantities in vivo (Docheva et al., 2008). Some researchers 
reported that in undifferentiated MSCs, there were several antibodies that react against 
Cluster of Differentiation (CD) 73 (membrane-bound ecto-5’-nucleotisidase), CD90 
(Thy-1), CD105 (endoglin) and CD166 (ALCAM), and thus, seem to be suitable for 
pure isolation of MSCs population (Barry and Murphy, 2004; Bobis et al., 2006; 
Schieker et al., 2007).  
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 Leo and Grande (2006) have mentioned that MSCs can be influenced via a 
multitude of growth factor receptors that have been identified on their surface such as 
Epidermal Growth Factor Receptor, basic Fibroblast Growth Factor Receptor, Insulin 
Growth Factor Receptor, Platelet Derived Growth Factor Receptor, Transforming 
Growth Factor Beta Receptor type 1 (TGFβR1) and Transforming Growth Factor Beta 
Receptor type 2 (TGFβR2), and these growth factor receptors are important for MSC 
self-renewal and differentiation (Park et al., 2011b).  
 
The proliferation and differentiation of MSCs are regulated through a variety 
of peptides such as NANOG, Oct4, and signalling pathways such as Transforming 
Growth Factor Beta (TGF-β) signalling pathway. Chambers et al. (2007) reported that 
the transcription factors Oct4, NANOG and Sox2 are very important for the efficient 
maintenance of pluripotent cell identity and they found that the expression of Oct4 and 
NANOG were detected during development such as in adult tissues; meanwhile, 
expression of Sox2 was not expressed. Other than that, Rex1 has also been suggested 
as one of the pluripotency markers (Son et al., 2013). The expression of this gene has 
been reported to be limited in the inner cell mass of blastocysts, which retain the 
potential of pluripotency differentiation, and subsequently down regulated during the 
later stages of differentiation in the epiblast and primitive ectoderm (Mignotte and 
Vayssiere, 1998; Yu et al., 2011). Scotland et al. (2009) also reported that the 
expression of Rex1 affected the differentiation, cell cycle regulation, and cancer 
progression in cells. Nestin and vimentin are both intermediate filament (IF) proteins 
which also have been chosen as mesenchymal stem cell marker. Nestin expression has 
been associated with early stages of development of cells which have been reported in 
a review by Xie et al. (2015) where several researchers have mentioned that bone 
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marrow-derived MSCs expressed nestin before differentiation in vitro (Tondreau et 
al., 2004), and this gene was enriched in embryonic stem cell-derived progenitor cells 
that could develop into neuroectodermal, endodermal, and mesodermal lineages 
(Wiese et al., 2004). On the other hands, vimentin has been mostly utilised in EMTs 
which occurred during embryogenesis and metastasis (Mendez et al., 2010). 
 
2.3 Dental stem cells sources 
 
Dental stem cells have been recognised as one of the stem cells sources that can be 
used for regenerative medicine. Dental stem cells were first isolated from dental pulp 
(DPSCs) by Gronthos and his colleagues (Gronthos et al., 2000) and from exfoliated 
deciduous teeth (SHED) (Miura et al., 2003). Other than that, dental stem cells can 
also be extracted from periodontal ligament stem cells (PDLSCs) (Seo et al., 2004), 
stem cells from apical papilla (SCAP) (Sonoyama et al., 2006; Sonoyama et al., 2008), 
dental follicle progenitor cells (DFPCs) (Morsczeck et al., 2008) (Figure 2.1) and the 
recent finding is pluripotent-like stem cells derived from dental pulp (DPPSCs) (Atari 
et al., 2012).    
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Figure 2.1 Schematic image showing the location of dental stem cells niches 
(Abdullah et al., 2016) 
 
2.3.1 Dental pulp stem cells  
 
Dental pulp stem cells (DPSCs) were first discovered by Gronthos et al. (2000) from 
human adult dental pulp, which are capable to regenerate a dentin-pulp-like complex. 
These stem cells can easily be obtained from discarded permanent teeth and harvested 
with less invasive and safe manner. DPSCs have shown to have higher angiogenic, 
neurogenic, and regenerative possibilities as compared to stem cells from bone marrow 
and adipose tissue (Ishizaka et al., 2012) which may serve as alternate versatile stem 
cell sources for cellular biological therapies.  
 
 DPSCs can be extracted from discarded permanent teeth comprising of third 
molars, supernumerary teeth, displaced teeth and orthodontically unnecessary teeth 
(Nakashima et al., 2013). These stem cells have been found to display highly 
proliferative, self-renewal, and capacity to differentiate into other lineages (Gronthos 
et al., 2000). Other than that, previous study on animal also has shown that DPSCs 
have a greater potential in repair and regeneration from various tissues, such as heart 
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(Gandia et al., 2008), muscles (Kerkis et al., 2008), teeth (Nedel et al., 2009) and bone 
(Graziano et al., 2008). Interestingly, in 2009, d’Aquino and his co-workers had 
successfully accomplished the first clinical trial on patient using DPSCs application 
for bone reconstruction (d’Aquino et al., 2009). Karbanová et al. (2010) reported that 
when they cultured isolated DPSCs in a medium with low level of serum in the 
presence of epidermal growth factor (EGF) and platelet-derived growth factor BB 
simultaneously, the stem cells revealed antigenic profile of mesenchymal and neural 
markers with several markers of embryonic stem cells. This supported that these stem 
cells can differentiate into multi-lineage cells. However, DPSCs have shown to have 
lower proliferation rate compared to SHED (Wang et al., 2012).  
   
2.3.2 Stem cells from human exfoliated deciduous teeth  
 
Another source of stem cell derived from dental tissues is stem cells from human 
exfoliated deciduous teeth or known as SHED. These stem cells have received growing 
attention in recent years due to its common characteristics with other MSCs pertaining 
to easiness of obtainment and propagation (Bluteau et al., 2008). SHED was first 
isolated by Miura and his co-workers, and these stem cells were identified to be a 
population of highly proliferative, clonogenic cells capable of differentiating into a 
variety of cell types including neural cells, adipocytes, and odontoblasts (Miura et al., 
2003; Fazliah et al., 2010; de Sá Silva et al., 2014). Due to its advantages of a higher 
proliferation capability, abundant cell supply, and painless stem cell collection with 
minimal invasion, SHED could provide a better option as a stem cell source for 
potential therapeutic application. 
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 Several studies have shown the capability of SHED to differentiate into other 
lineage of cells. For example, in 2009, Nam and Lee successfully induced primary 
SHED to differentiate into epithelial-like cells when cultured in KGM (Nam and Lee, 
2009). Later, Wang and his associates differentiated SHED into dopaminergic neuron-
like cells which could be the sources in treating Parkinson disease’s patients (Wang et 
al., 2010). In 2013, another achievement was achieved when SHED was successfully 
transplanted into full-length root canals with injectable scaffolds; these stem cells were 
capable to proliferate within the root canal and expressed markers of odontoblastic 
differentiation (dentin sialophosphoprotein, dentin matrix acidic phosphoprotein, and 
matrix extracellular phosphoglycoprotein) after 28 days in vitro (Rosa et al., 2013). 
 
 There are also several signalling transductions that have been investigated 
related to SHED culture. TGF-β, extracellular signal-regulated kinase (ERK), protein 
kinase B, Wnt, and Platelet Derived Growth Factor (PDGF) signalling also have been 
shown to be activated in SHED cultured (Yamaza et al., 2010). Besides, Bento et al. 
(2012) reported that mitogen activated-protein kinase kinase (MEK1)/ERK signalling 
was required for differentiation of SHED into endothelial cells. Furthermore, Notch 
signalling was also involved in SHED cultured in specific differentiation medium, 
KGM by expressing the Notch gene molecules (Taha et al., 2015).  
 
2.3.3 Periodental ligament stem cells   
 
Multipotent PDLSCs were first described by Seo et al. (2004) when it was observed 
that these stem cells were capable to differentiate into cementoblast-like cells, which 
later can be used to renew the damaged tissues caused by periodontal disease. These 
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stem cells originated from perivascular space of the periodontium and have been found 
to possess mesenchymal stem cell characteristics, thus a promising tool for periodontal 
regeneration (Zhu and Liang, 2015). Due to PDLSCs capabilities, several researchers 
have mentioned that these cells also can differentiate into periodontal ligaments, 
alveolar bone, cementum, peripheral nerves, and blood vessels (Liu et al., 2008; Huang 
et al., 2009a; Park et al., 2011a). 
 
2.3.4 Stem cells from apical papilla  
 
Stem cells from apical papilla (SCAP) were first discovered by Sonoyama et al. (2006) 
in human permanent immature teeth. These multipotent stem cells also have been 
found to express numerous neurogenic markers such as nestin and neurofilament 
medium, indicating that this stem cells originated from neural crest (Sonoyama et al., 
2008). Furthermore, SCAP has been demonstrated to own a significantly higher 
mineralisation potential as well proliferation rate compared to DPSCs (Bakopoulou et 
al., 2011). Research has also been carried out to investigate signalling pathways such 
as Notch signalling associated with SCAP (Jamal et al., 2015). 
 
2.3.5 Dental follicle progenitor cells 
 
Other interesting stem cells were dental follicle progenitor cells (DFPCs), which are 
loose connective tissues and was found by Morsczeck et al. (2005), Kemoun et al. 
(2007) and d'Aquino et al. (2011). They also reported that DFPCs acquired 
mesenchymal progenitor characteristics such as fibroblast-like morphology and 
expressed several mesenchymal markers such as Notch-1, nestin, and STRO-1. 
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Furthermore, also reported these stem cells also were derived from neural crest, and 
thus have different source from bone marrow-derived MSCs. 
 
2.3.6 Dental pulp pluripotent-like stem cells  
 
Recently, in 2012, Atari and his colleague successfully identified stem cell populations 
with embryonic-like morphology derived from human dental pulp from third molar, 
also known as dental pulp pluripotent-like stem cells (DPPSCs). They claimed that it 
was the first report available regarding DPPSCs. Based on their study, they were able 
to isolate these stem cells using culture media containing leukaemia inhibitor factor 
(LIF), EGF, and PDGF (Atari et al., 2012).  
 
2.4  Transforming Growth Factor Beta (TGF-β) 
 
TGF-β family consists of a huge number of structurally related polypeptide growth 
factors, each of which can regulate an array of cellular processes including cell 
proliferation, lineage determination, differentiation, motility, adhesion, and cell death 
(Xie et al., 2003; Massagué and Gomis, 2006; Massagué, 2012). The TGF-β family is 
highly conserved in mammals and plays a central role in regulating cell functionality 
for survival (Fleisch et al., 2006; Taylor et al., 2009). In mammals, three isoforms of 
TGF-β, namely, TGF-β1, TGF-β2, and TGF-β3 have been discovered (Saharinen and 
Keski-Oja, 2000; Massagué, 2012). These TGF-βs are multifunctional cytokines 
which can regulate cell proliferation and differentiation positively or negatively 
depending on the cell type (Hauri-Hohl et al., 2008), and have been implicated in such 
diverse physiological events such as angiogenesis, steroidogenesis, immune function 
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and tissue remodelling and repair (Leask and Abraham, 2004; Bujak and 
Frangogiannis, 2007; Azmi et al., 2013). The TGF-βs have been shown to be involved 
in a wide variety of cellular processes in cells and tissues such as fibroblast, epithelium, 
bone and extracellular matrix (ECM) (Govinden and Bhoola, 2003). 
 
The TGF-β receptors are TGF-βR1, TGF-βR2, and TGF-βR3 and the 
biological processes occur when the TGF-β molecule interact with the cell surface 
receptors (Massagué, 2012). The TGF-β binds to the cell surface receptor TGF-βR2 
but not TGF-βR1 even though both are cytoplasmic serine/threonine kinase domains. 
The TGF-βR1 recognises the heterodimer complex of TGF-β-TGF-βR2 and undergoes 
phosphorylation. Once the TGF-βR1 is phosphorylated, SMAD2 and SMAD3 proteins 
are activated. The process is inhibited by SMAD7. The SMAD4 proteins then attach 
to SMAD2 and SMAD3 proteins, undergo phosphorylation and become activated. 
These SMAD2/3/4 protein complexes are translocated to the nucleus and together with 
co-factor, co-repressor and transcription factor, and then the SMADs complex will 
regulate the transcription of target genes to mediate the biological process of TGF-β 
(Massagué et al., 2005; Massagué, 2012). 
 
In contrast to TGF-β2 and TGF-β3, TGF-β1 is being intensely studied in the 
TGF-β signalling pathway and this isoform has been correlated with epithelial 
formation in many cellular biological processes (Massagué and Xi, 2012). Gao and his 
colleague found that TGF-β1 was expressed in the inner of dental epithelium before 
the enamel matrix secretion and the expression of TGF-βRI was weekly detected in 
inner dental epithelium (Gao et al., 2009). This finding has proved that TGF-β 
signalling plays a crucial role during enamel organ development. Nonetheless, there 
18 
 
are many more signalling pathways that can be involved in cell growth and 
proliferation such as mitogen-activated protein kinase, Smad, Wnt, Hedgehog and 
Notch signalling pathways (Derynck and Zhang, 2003; Moustakas and Heldin, 2005; 
Duronio and Xiong, 2013). 
 
Modified figure reproduced from Hui and Friedman (2003) 
Figure 2.2 The transforming growth factor-β (TGF-β) signalling pathway 
 
2.5 Activin like kinase – 5 (ALK-5) inhibitor 
 
ALK-5 inhibitor is a small molecule that has been developed to inhibit the TGF-β 
receptor type 1 (ALK-5). This molecule has been created for therapeutic use in cancer 
and other types of disease where overexpression of TGF-β1 is linked to a disease 
phenotype (Markell et al., 2010). In this study, they found that pharmacological 
inhibition of TGF-β signalling also blocks tumour outgrowth in part through inhibition 
19 
 
of TGF-β dependent epidermal inflammation. However, they also found that the 
differential outgrowth of premalignant lesion with an inflammatory phenotype similar 
to squamous cell carcinoma following long-term treatment with SB431542 and at high 
risk for malignant conversion suggests that during tumour formation and premalignant 
progression may be different than on malignant tumours (Markell et al., 2010). 
SB431542 has been commercialised and shown to be selective for the kinase activity 
of ALK-5 and to a lesser extent of activin signalling receptor ALK-4 and the nodal 
receptor ALK-7 (Mori et al., 2004; Markell et al., 2010). ALK-5 inhibitor plays a 
crucial role as a competitive adenosine triphosphate-binding site kinase inhibitor 
(Markell et al., 2010; Yang et al., 2016) and some researchers reported that it has been 
shown to inhibit the in vitro phosphorylation of Smad2 (Inman et al., 2002) and Smad3 
(Callahan et al., 2002; Nyati et al., 2011). 
 
2.6 Epithelial cells 
 
Epithelia consist of cohesive sheets of cells which line the exterior and interior surfaces 
of our bodies, constituting a mechanical and chemical barrier between the body and its 
environment (Roignot et al., 2013; Le Bras and Le Borgne, 2014). These tissues play 
crucial roles in protection, filtration, absorption, excretion, and sensation (Kolahi and 
Mofrad, 2010).  
 
Epithelia is composed of epithelial cells and there are several classifications of 
these cells based on the cell shape and number of layers; squamous cells which are 
thin and flat, cuboidal cells which are cubical to round, and columnar cells which are 
tall and cylindrical (Moini, 2015). Then, the number of cell layers represent by 1) 
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simple epithelium which is single layer cells which typically involved in absorption, 
filtration, and secretion, and 2) stratified epithelium consist of multi-layered of cells 
where can be found in body lining to withstand mechanical and chemical stress. Apart 
from that, pseudostratified epithelium is a simple columnar epithelial cell, giving the 
misleading impression as stratified epithelium when the cells were viewed in cross 
section since the nuclei appeared at different heights; and translational epithelium is a 
stratified epithelium where it can change the shape such as cuboidal or squamous 
stratified depending on the stretching of the cells since they have elastic properties 
(Moini, 2015). According to Wikramanayake et al. (2014), keratinocytes are 
specialised epithelial cells located closely to the basal layer and have been found 
abundantly in epithelial cells. 
 
2.6.1 Keratinocytes 
 
Human skin consists of three main layers which are subcutaneous tissue (stratified), 
underlying dermis, and cellular epidermis (Williams, 2003; McGrath et al., 2004; 
Nelson et al., 2011; Huber et al., 2016). One of the components of epidermis layer 
includes keratinocytes which is located close to the basal layer to ensure its 
regeneration (Xavier Batista et al., 2010). Keratinocytes have been known as 
specialised epithelial cells which are found abundantly in epithelial cells and these 
cells have been synthesised as major components of epidermal barrier through a series 
of differentiation process (Wikramanayake et al., 2014). A typical intermediate 
filament (IF) protein, named keratins, are highly expressed in epithelial cells (Moll et 
al., 2008) and these keratins are important for the mechanical stability and integrity of 
epithelial cells and tissues (Ramms et al., 2013). In 1984, Steinert et al. (1984) 
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mentioned that there were two types of keratins; type I which was more acidic and 
differ from the basic type II based on their amino acid sequence. The type I keratin 
comprises of 28 keratin genes (K9–K10, K12–K28, and K31–K40) (including K33a 
and K33b) and type II consists of 26 keratin genes K1–K8 (including K6a, K6b and 
K6c) and K71–K86) (Moll et al., 2008). In human genome, these keratin genes are 
designated as KRT1, KRT2, KRT3, etc. (Schweizer et al., 2006). Other than that, 
several studies have also investigated the expression of epithelial markers such as E-
cadherin (Van Roy and Berx, 2008), 2008), Occludin, Desmoplakin, Mucin1 (Strauss 
et al., 2011), p63 (Yang et al., 1998; Nair and Krishnan, 2013), and pan-cytokeratin 
(Fuertes et al., 2013; Sidney et al., 2015) in normal cells or cancerous cells. Hence, 
these epithelial markers have been used in wide range of research. 
 
2.6.2 Keratinocyte Growth Medium  
 
Keratinocyte Growth Medium (KGM) is a specific culture medium used to culture 
epithelial cells. This media has been proved by Nam and Lee (2009) where they could 
identify the keratinocyte cell properties cultured from a MSC of SHED through 
immunofluorescence technique and Reverse – Transriptase Polymerase Chain 
Reaction (RT-PCR). Taha et al. (2015) has also used this differentiation medium to 
culture SHED to investigate the expression of Notch signalling pathway molecules. 
Besides, some researchers also used KGM to culture Herwig’s epithelial root sheath 
cells (Zeichner‐David et al., 2003; Farea et al., 2013). Additionally, Sonoyama and his 
colleagues also used keratinocyte-serum-free medium to culture HERS cells 
(Sonoyama et al., 2007). This medium is supplied without serum and bovine pituitary 
extract (BPE), have insulin, and growth supplements that are crucial to isolate and 
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growing the human keratinocyte cells. BPE acts as mitogenic supplement in serum-
free growth medium (Kent and Bomser, 2003) which could induce mitosis and 
transformation (Xu et al., 2013b). 
 
2.7 Stem cell markers used in the analysis of SHED cultured in KGM treated 
with TGF-β1 and ALK-5 inhibitor 
 
2.7.1 NANOG 
 
NANOG is encoded by NANOG protein in human. It is a core transcription factor 
protein which critically involved in self-renewal of undifferentiated ESC and has 
emerged as one of the master regulators of stem cells pluripotency and differentiation 
(Boyer et al., 2005; Kalmar et al., 2009). Due to that, NANOG has been chosen as one 
of the stem cells marker and used by researchers in wide range of studies. There are 
several studies conducted to investigate the expression of NANOG based on its 
pluripotency (Abranches et al., 2014), cancer cells (Park et al., 2012; Shan et al., 2012; 
Habu et al., 2015), and chromatin organisation in mouse embryonic stem cells (Novo 
et al., 2016). Other than that, NANOG collaborates with Sox2 and Oct4 to maintain 
the pluripotency of ESCs (Kalmar et al., 2009). Overexpression of NANOG has been 
shown to support the self-renewal of cells, although the study was conducted in mouse 
ESC in the absence of LIF (Chambers et al., 2003; Silva et al., 2006).   
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2.7.2 Nestin 
 
Nestin is a type VI IF protein which is also known as neural stem/progenitor cell 
marker (Guérette et al., 2007). It has been found to express in undifferentiated central 
nervous system (CNS) cells during development, but also in normal adult CNS and 
CNS tumour cells (Suzuki et al., 2010). The downregulation of nestin has been linked 
to the differentiation of cell into neurons or glial cells (Di et al., 2014). Since nestin is 
an IF protein type, it has been shown to form homodimers and homotetramers 
structure, however nestin was unable to form IF protein in vitro without co-assembling 
with purified vimentin or type IV IF protein (Herrmann et al., 2009; Thomsen et al., 
2013). Other than that, nestin has also been used as a stem cell marker since this protein 
emerges from neuroectoderm lineage (Noisa et al., 2012). In addition, although the 
expression of nestin has been first reported in neuroepithelial stem cells (Lendahl et 
al., 1990), it has been then be reported presence in other types of cells such as 
endothelial cells (Suzuki et al., 2010), cancer cells (Krupkova et al., 2010), fibroblast 
(Kishaba et al., 2010), and other tissues such as tooth bud, testes, hair follicle sheath, 
skin, pancreas, and newly formed blood vessels (Zulewski et al., 2001; Wiese et al., 
2004; Du et al., 2011; Abe et al., 2012).   
  
2.7.3 Rex1 
 
Rex1 protein has been associated with pluripotency of cells in undifferentiated ESC of 
both embryo and adult (Scotland et al., 2009). Due to the differentiation process, the 
expression of Rex1 gene is downregulated (Scotland et al., 2009; Glemzaite and 
Navakauskiene, 2016). Since Rex1 expression has been showed to express specifically 
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related to pluripotency in mouse and human ES cells, this gene has been one of the 
well-known pluripotency marker, and has been used as a marker for multipotent adult 
progenitor cells and amniotic fluid cells (Masui et al., 2008). Other than that, Shi et al. 
(2006) reported that NANOG is significantly associated with Rex1 since it is a 
transcription activator for Rex1 promoter. Thus, when NANOG is knocked out, the 
Rex1 expression was reduced, or Rex1 expression increased when the NANOG was 
stimulated. In addition, Son et al. (2013) reported that in human pluripotent stem cells, 
with depletion of Rex1, the cells lost their self-renewal capacity and their potential to 
differentiate, especially in their mesoderm lineage.  
 
2.7.4 Vimentin 
 
Vimentin is a protein that has been encoded as VIM gene in human. It is a type III IF 
protein which has been used widely as a marker for EMT during embryogenesis and 
metastasis (Mendez et al., 2010). However, vimentin also is expressed in epithelial 
cells during the EMT under both physiological and pathological processes (Gupta and 
Massague, 2006), which has been supported in review by Kokkinos et al. (2007) and 
(Vechio et al., 2011). Vimentin also acts as a critical player in the physiologic 
endothelial mechanical response towards endothelial phenotype (Conway et al., 2013). 
Other than that, there is a study that suggests vimentin involvement in wound healing 
(Menko et al., 2014) by regulating fibroblast proliferation, TGF-β1–Slug signalling, 
collagen accumulation, and EMT processing, where all these are required for 
keratinocyte activation (Cheng et al., 2016).  
 
